Kestra Medical names Daniel Finney VP of research and development
Go back to Kestra Medical names Daniel Finney VP of research and development| (NASDAQ: KMTS) | Delayed: 23.57 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.57 | 52 Week High | $ | |||
| Open | $23.57 | 52 Week Low | $ | |||
| Day High | $23.57 | P/E | N/A | |||
| Day Low | $23.57 | EPS | $ | |||
| Volume | 106 | |||||

